rs368435864
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_002693.3(POLG):c.3287G>T(p.Arg1096Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,620 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_002693.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251306Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135828
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461620Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727126
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
p.Arg1096Leu (CGT>CTT): c.3287 G>T in exon 21 of the POLG gene (NM_002693.2). The R1096L mutation has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. The R1096L mutation is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Another mutation at this position (R1096H) has also been reported as pathogenic in a patient with a clinical diagnosis of Alpers syndrome who had a second POLG mutation on the other allele (Horvath et al., 2006). Therefore, we interpret R1096L to be a pathogenic mutation. The variant is found in EPILEPSY panel(s). -
Progressive sclerosing poliodystrophy Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 1096 of the POLG protein (p.Arg1096Leu). This variant is present in population databases (rs368435864, gnomAD 0.003%). This missense change has been observed in individual(s) with clinical features of autosomal recessive POLG-related conditions (PMID: 32600829). ClinVar contains an entry for this variant (Variation ID: 206559). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt POLG protein function with a positive predictive value of 95%. This variant disrupts the p.Arg1096 amino acid residue in POLG. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21305355, 21880868, 22189570, 24265579, 28471437, 30167885). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at